Cell Impact (OSTO:CI) Other Financing: kr32.78 Mil (TTM As of Mar. 2026)


What is Cell Impact Other Financing?

Cell Impact OSTO:CI -1.66% Other Financing is kr32.78 Mil as of Mar. 2026. The stock has 7 warning signs investors should review.

Cell Impact's Other Financing for the three months ended in Mar. 2026 was kr-1.05 Mil.

Cell Impact's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was kr32.78 Mil.

Cell Impact Other Financing Historical Data

* Premium members only.

The historical data trend for Cell Impact's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cell Impact Other Financing Chart

Cell Impact Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -45.84 -21.90 -8.18 -5.40

Cell Impact Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.78 34.72 -0.12 -1.05

Cell Impact Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr32.78 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of kr32.78 Mil mean?
Cell Impact (OSTO:CI) has a Other Financing of kr32.78 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Cell Impact and its competitors.
Is Cell Impact's Other Financing too high?
Cell Impact's current Other Financing is kr32.78 Mil.
How does Cell Impact's Other Financing compare to CRS and ATI?
Cell Impact's Other Financing of kr32.78 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for an Industrial Products company?
A good Other Financing depends on the Industrial Products industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Cell Impact and its competitors. Cell Impact's current Other Financing is kr32.78 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Impact stock overvalued right now?
Based on GuruFocus' analysis, Cell Impact (OSTO:CI) is currently considered Modestly Overvalued. The stock's GF Value™ is kr0.06, compared to a current price of kr0.08 — trading 28% above its estimated fair value. The current Other Financing is kr32.78 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Cell Impact (OSTO:CI), the current Other Financing is kr32.78 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cell Impact Business Description

Other Exchanges ICL:Germany
Address Kallmossvagen 7A, Karlskoga, SWE, 691 52
Cell Impact develops and manufactures flow plates for fuel cells and electrolyzers using materials such as graphite, stainless steel, and titanium. The company has developed and patented a high-velocity forming method, known as Cell Impact Forming, which enables the production of flow plates with advanced designs. Geographically, it operates in Sweden, Asia, the U.S., and Other Europe. It generates the majority of its revenue from Sweden.